Mountable Printable Placard With Headband
A resilient headband in a shape for being mounted on the head of the user. The headband is equipped with a longitudinal slotted member for holding a placard.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8182837 | Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness The present invention relates to methods for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed with respiratory illness by administering an analgesic composition comprising a sub-analgesic dosage of a p-op... | 05/22/2012 |
| 8158152 | Lyophilization process and products obtained thereby A lyophilization process which comprises dissolving a material in one or more solvents for said material to form a solution; forcing said material at least partially out of solution by combining the solution and a non-solvent for the material, which non-solvent is m... | 04/17/2012 |
| 8012990 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method m... | 09/06/2011 |
| 8003783 | 17B-hydroxysteroid dehydrogenase inhibitors There is provided a compound of Formula (III) wherein R1 is a selected from an alkyloxyalkyl group, a nitrile group, alkylaryl group, alkenylaryl group, alkylheteroaryl group, alkenylheteroaryl group... | 08/23/2011 |
| 7985733 | Buffer-based method for preparing bivalirudin drug product A method for preventing the formation of a bivalirudin precipitate during preparation of a pharmaceutical drug product comprising about 250 mg of bivalirudin, a dried bivalirudin drug product, and a concentrated liquid bivalirudin drug product. The method for preven... | 07/26/2011 |
| 7968561 | Steroidal compounds as steroid sulphatase inhibitors There is provided a compound having Formula I wherein G is a fluorocarbyl group, and wherein R1 is any one of a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide... | 06/28/2011 |
| 7923453 | Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method m... | 04/12/2011 |
| 7893284 | Oestrogen derivatives as inhibitors of steroid sulphatase The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the... | 02/22/2011 |
| 7846894 | Chinese hamster apoptosis-related genes Provided is an isolated polypeptide comprising a Cricetulus griseus sequence capable of mediating apoptosis of a cell, the sequence being selected from a FAIM sequence shown as SEQ ID NO: 1; a FADD sequence shown as SEQ ID NO: 2; a PDCD6 sequence shown as SEQ... | 12/07/2010 |
| 7838013 | Specific epitope based immunological diagnosis of tuberculosis The currently used method for immunological diagnosis of tuberculosis infection, the tuberculin skin test, is problematic for a number of reasons; it has low specificity in BCG vaccinated individuals, a high interobserver variance and requires skill to be read and i... | 11/23/2010 |
| 7803762 | Ready-to-use bivalirudin compositions Ready-to-use bivalirudin compositions, methods of using the ready-to-use bivalirudin compositions, and methods of preparing the ready-to-use bivalirudin compositions. The ready-to-use bivalirudin compositions comprise bivalirudin and one or more stabilizing agents. ... | 09/28/2010 |
| 7790419 | Antiviral vectors A viral vector production system is provided which system comprises: (i) a viral genome comprising at least one first nucleotide sequence encoding a gene product capable of binding to and effecting the cleavage, directly or indirectly, of a second nucle... | 09/07/2010 |
| 7772274 | Docetaxel formulations with lipoic acid Pharmaceutical formulations comprising docetaxel, solubilizer, and α-lipoic acid, wherein the formulation is substantially free of polysorbates and polyethoxylated castor oil. The solubilizer may comprise glycofurol, acetic acid, benzyl alcohol, or ethanol. The α-... | 08/10/2010 |
| 7713928 | Ready-to-use bivalirudin compositions Ready-to-use bivalirudin compositions, methods of using the ready-to-use bivalirudin compositions, and methods of preparing the ready-to-use bivalirudin compositions. The ready-to-use bivalirudin compositions comprise bivalirudin and one or more stabilizing agents. ... | 05/11/2010 |
| 7678758 | Method for enhancing T cell reactivity toward tumour antigens Provided is a method of vaccinating a patient against a tumor by administering an agent to reduce or prevent interaction between Notch and a Notch ligand, or expression or processing of Notch or a Notch ligand. In one embodiment, this is accomplished by administerin... | 03/16/2010 |
| 7659113 | Delivery system A retroviral delivery system capable of transducing a target site is described. The retroviral delivery system comprises a first nucleotide sequence coding for at least a part of an envelope protein; a second nucleotide sequence coding for at least a part of an enve... | 02/09/2010 |
| 7645918 | Method of plastid transformation in , vector for use therein and plants thus obtained The present invention relates to a method for the transformation of plastid genomes of plant species, in particular Asteraceae plant species, comprising the steps of providing a transformation vector carrying a DNA sequence of interest; subjecting a plant mat... | 01/12/2010 |
| 7632530 | Process for the preparation of high purity phytosterols The present invention provides an isolation process of the pure sterols from the SODD by simple acid catalyzed esterification and the separation of the reagents by distillation and water washing followed by the crystallization of phytosterols and purification. Soybe... | 12/15/2009 |
| 7629936 | Broad-band Fermi antenna design method, design program, and recording medium containing the design program There is provided a method for designing a corrugated Fermi antenna having a broad-band and circular directivity required for receiving an image by using a wave of millimeter order. As a first step, an inflection point of the Fermi-Dirac function as a taper function... | 12/08/2009 |
| 7598343 | Pharmaceutical formulations of bivalirudin and processes of making the same Pharmaceutical batch(es) or pharmaceutical formulation(s) comprising bivalirudin as the active ingredient, and a method of preparing the pharmaceutical batch(es) or pharmaceutical formulation(s). The pharmaceutical batch(es) or pharmaceutical formulation(s) may have... | 10/06/2009 |
| 7585676 | Retroviral vector Provided herein is a retroviral vector comprising, and capable of expressing, a nucleotide of interest (NOI), wherein the NOI encodes an RNA or protein which is harmful to a cell. ... | 09/08/2009 |
| 7582727 | Pharmaceutical formulations of bivalirudin and processes of making the same Pharmaceutical batch(es) or pharmaceutical formulation(s) comprising bivalirudin as the active ingredient, and a method of preparing the pharmaceutical batch(es) or pharmaceutical formulation(s). The pharmaceutical batch(es) or pharmaceutical formulation(s) may have... | 09/01/2009 |
| 7504562 | Lettuce variety The present invention relates to a Lactuca sativa L. var. longifolia Lam seed designated as 41-52 RZ, referred to as Nirvanus, which exhibits resistance against downy mildew (Bremia lactucae Regel), currant-lettuce aphid (Nasonovia ribis-... | 03/17/2009 |
| 7498038 | Chitin microparticles and their medical uses The present invention relates to chitin microparticles and their medical uses, in particular in the treatment of allergy, or the treatment of conditions that would benefit from an upregulation of the cell mediated immune system, or an up-regulation of natural killer... | 03/03/2009 |
| 7476545 | Method of quickly detecting and/or assaying antigen by fluorescence correlation spectrometry The present invention provides a method of quickly and accurately detecting and/or assaying an antigen using fluorescence correlation spectroscopy (FCS), which involves a fluorescence-labeled antibody fragment and a non-fluorescence-labeled intact antibody that form... | 01/13/2009 |
| 7462462 | Peptide capable of binding to nanographite structures It is intended to provide a peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric... | 12/09/2008 |
| 7420029 | Tissue-specific transporter inhibitor The present invention is to provide a tissue-specific transporter inhibitor which is not absorbed through the digestive tract and can prevent deterioration in the QOL of a patient caused by diet therapy, and a therapeutic drug for tissue dysfunction diseases and a t... | 09/02/2008 |